Fingerprint
Dive into the research topics of 'Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Steven M. Horwitz, Robert S. Negrin, Karl G. Blume, Sheila Breslin, Monic J. Stuart, Keith E. Stockerl-Goldstein, Laura J. Johnston, Ruby M. Wong, Judith A. Shizuru, Sandra J. Horning
Research output: Contribution to journal › Article › peer-review
208
Scopus
citations